Pharmacoeconomic Analysis of Pefloxacin vs Ceftazidime in Treatment of Lower Respiratory Tract Infections in Adults / 中国药房
China Pharmacy
;
(12)2001.
Artículo
en Chino
| WPRIM
| ID: wpr-517865
ABSTRACT
OBJECTIVE:
To discuss the economic efficiency of different antimicrobials in treatment of lower respiratory tract infections(LRTI)METHODS:
50 cases of LRTI collected from this hospital were divided into two groupsA,pefloxacin;B,ceftazidime Evaluation was carried out with pharmacoeconomic cost-effectiveness analysisRESULTS:
The total costs were 957 60 yuans and 1 596 00 yuans and the effective rates were 84% and 92% in group A and B respectively An increase of 1%effective rate in group A saved 79 80 yuans in comparison with that in group BCONCLUSION:
The therapeutic scheme of pefloxacin seems to be the best one for treating LRTI
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
China Pharmacy
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS